
The zzso and clinical development of zzso a humanized zzso zzso directed against a zzso zzso in the zzso zzso zzso relied heavily on the use of animal models to validate zzso as a potential zzso zzso The identification of zzso zzso as a zzso was first established in a zzso brain tumor in the zzso zzso mouse technology led to an understanding of the role of zzso in zzso of breast zzso zzso studies of human zzso zzso into zzso zzso models further explored the role zzso plays in tumor progression and zzso A zzso zzso capsule fresh human tumor zzso zzso was zzso to test efficacy of various zzso zzso zzso zzso and the data were helpful in choosing the most zzso for subsequent human engineering for clinical zzso zzso zzso models in zzso mice were used to test the efficacy of zzso zzso develop zzso zzso measure drug interactions between zzso and chemotherapy, and zzso dosing schedules of zzso combined with zzso In this work, we will highlight the utility of animal models exploited in the development of zzso - noting not only their contribution to drug development but also their limitations in translation of zzso data into the zzso It is likely that the experience we gained in the case of zzso animal models to study in zzso effects of zzso have parallels in the development of other zzso zzso since overcoming the species boundaries zzso zzso with zzso zzso development of zzso zzso zzso and zzso interaction with zzso zzso receptors on immune zzso zzso are major limitations in the design and interpretation of zzso experiments designed to fulfill various regulatory requirements prior to initiation of phase I human clinical zzso 

